Proactive Investors - Run By Investors For Investors

Futura Medical Plc chief on results and upcoming product launches

James Barder, chief executive of Futura Medical Plc (LON:FUM) says 2015 was a “very active year” for the company, with one clinical trial completed and another to be finished in the near future.

Spending is typically around £2.5mln, Barder says, but the company has roughly doubled that, due to the investment into the clinical trials.

He expects to begin the roll-out of several products over the coming year, and adds that he is “delighted to announce that one of our key distributors have already placed an order [for its CSD500 condom], and manufacturing production will start very shortly on that”.

Other product launches are expected throughout the year, and the firm is working with other distributors, with Barder expecting to announce “at least one new deal this year.”

Meet Premier African Minerals Ltd, Anglo Asian Mining Plc and Thor Mining PLC at our event, London, 21 September 2017. Register here »
Why Invest In Futura Medical plc.? Read More Here

Register here to be notified of future Futura Medical plc. articles
View full FUM profile View Profile

Futura Medical plc. Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use